WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regression
Thomas Sorz‐Nechay(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Ksenia Brusilovskaya(Austrian Academy of Sciences), Stefan Günther Kauschke, Benedikt Simbrunner(Austrian Academy of Sciences), Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Philipp Schwabl(Austrian Academy of Sciences), Peng Sun(Tongren Hospital), Ines Truebenbach(Boehringer Ingelheim (Germany)), Katharina Regnat(Medical University of Vienna), Katharina Bonitz(Austrian Academy of Sciences), Oleksandr Petrenko(Austrian Academy of Sciences), Benedikt Hofer(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), Henriette Horstmeier(Medical University of Vienna), Larissa Pfisterer(Boehringer Ingelheim (Germany)), Kerstin Zinober(Medical University of Vienna), Philipp Königshofer(Medical University of Vienna)
Cited by 0
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399